Melody Cobleigh to Maytansine
This is a "connection" page, showing publications Melody Cobleigh has written about Maytansine.
Connection Strength
0.119
-
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates. Cancer Chemother Pharmacol. 2014 Aug; 74(2):399-410.
Score: 0.119